Business Context and Reporting Period
IDEAYA Biosciences, Inc. filed this Form 8-K on November 14, 2023, to disclose the entry into a material definitive agreement. The company is incorporated in Delaware and trades on the Nasdaq Global Select Market under the symbol IDYA.
Key Financial Metrics
This filing does not report revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on a new contractual obligation.
- New Lease Obligation: Total base rent of $1,581,469 USD over the initial term (net of rent abatement).
- Lease Term: Initial term of 4 years and 3 months, commencing no later than January 1, 2024.
- Renewal Option: One 3-year option to renew at prevailing market rates.
Material Changes
The company entered into an Office Lease Agreement with AAT TORREY 13-14, LLC for approximately 6,000 square feet of office space at 11710 El Camino Real, San Diego. This lease serves as both a replacement and an expansion of the company's current San Diego office space.
Outlook, Risks, and Contingencies
The lease contains customary provisions allowing the landlord to terminate the agreement if the company fails to remedy a breach of obligations within specified time periods. The full text of the lease will be filed as an exhibit to the company's Annual Report on Form 10-K for the fiscal year ending December 31, 2023.
Investor Verification Checklist
- Verify the exact commencement date of the lease, which is contingent on the completion of pre-occupancy work or December 1, 2023.
- Review the full Office Lease Agreement (to be filed in the 2023 Form 10-K) for specific details on rent abatement schedules and termination clauses.
- Assess the impact of the $1.58 million rent obligation on the company's future cash flow projections.